Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer

Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer

Muscle-invasive bladder cancer (MIBC) remains a pressing health concern due to conventional treatment failure and significant molecular heterogeneity, hampering the development of novel targeted therapeutics. In our quest for novel targetable markers, recent glycoproteomics and bioinformatics data h...

Full description

Bibliographic Details
Main Authors: Eduardo Ferreira, Dylan Ferreira, Marta Relvas-Santos, Rui Freitas, Janine Soares, Rita Azevedo, Luís Pedro Afonso, Luís Lima, Beatriz Santos, Martina Gonçalves, André M. N. Silva, Lúcio Lara Santos, Andreia Peixoto, José Alexandre Ferreira
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:International Journal of Molecular Sciences
Subjects:
glycomics
glycoproteomics
bladder cancer
targetable biomarkers
GLUT1
Online Access:https://www.mdpi.com/1422-0067/25/6/3462

Internet

https://www.mdpi.com/1422-0067/25/6/3462

Similar Items